What should a clinical pharmacologist know to start a clinical trial (phase I and II)?: proceedings of symposium 10, 2nd congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Berlin, September 17 - 20, 1997 ; 14 tables
Saved in:
| Format: | Book |
|---|---|
| Language: | English |
| Published: |
München [u.a.]
Zuckschwerdt
1998
|
| Series: | Klinische Pharmakologie
16 |
| Subjects: | |
| Online Access: | Inhaltsverzeichnis |
| Physical Description: | VIII, 67 S. graph. Darst. |
| ISBN: | 3886036332 |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV012036234 | ||
| 003 | DE-604 | ||
| 005 | 19990413 | ||
| 007 | t | ||
| 008 | 980624s1998 gw d||| |||| 10||| eng d | ||
| 016 | 7 | |a 953901653 |2 DE-101 | |
| 020 | |a 3886036332 |c hardcover : DM 85.00, sfr 77.00, S 621.00 |9 3-88603-633-2 | ||
| 035 | |a (OCoLC)845083220 | ||
| 035 | |a (DE-599)BVBBV012036234 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c DE | ||
| 049 | |a DE-12 |a DE-19 |a DE-355 | ||
| 084 | |a XI 1400 |0 (DE-625)152974:12905 |2 rvk | ||
| 084 | |a 7,41 |2 ssgn | ||
| 245 | 1 | 0 | |a What should a clinical pharmacologist know to start a clinical trial (phase I and II)? |b proceedings of symposium 10, 2nd congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Berlin, September 17 - 20, 1997 ; 14 tables |c J. Kuhlmann ... (eds.) |
| 264 | 1 | |a München [u.a.] |b Zuckschwerdt |c 1998 | |
| 300 | |a VIII, 67 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Klinische Pharmakologie |v 16 | |
| 650 | 0 | 7 | |a Klinische Prüfung |0 (DE-588)4031192-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1997 |z Berlin |2 gnd-content | |
| 689 | 0 | 0 | |a Klinische Prüfung |0 (DE-588)4031192-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Kuhlmann, Jochen |e Sonstige |4 oth | |
| 710 | 2 | |a European Association for Clinical Pharmacology and Therapeutics |e Sonstige |0 (DE-588)5251718-4 |4 oth | |
| 830 | 0 | |a Klinische Pharmakologie |v 16 |w (DE-604)BV004070946 |9 16 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008144902&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 940 | 1 | |n oe | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-008144902 | ||
| 942 | 1 | 1 | |e 22/bsb |g 471 |
Record in the Search Index
| _version_ | 1804126631216807936 |
|---|---|
| adam_text | Contents
KuhlmannJ., Mrozikiewicz A. Preface and Introduction VII
Dayan A. D. (London): Before the first dose and the first phase II study in man:
What should the clinical pharmacologist know about a NCE? 1
Ingelman Sundberg M., Oscarson M. (Stockholm): Prediction of human drug
metabolism using in vitro systems 7
Wensing C, Kuhlmann J. (Wuppertal): Risk benefit evaluation from phase I data . 15
Meyer F. P., Troger U., Ansorge S., Ittenson A., Bank U., Buhling F., Lauter J.,
Rohl F. W. (Magdeburg): Dominance personality trait and immune system in
healthy volunteers Are they criteria for clinical trials? 25
Cleophas T. J. M., Niemeyer M. C, Zwinderman A. H. (Sliedrecht, Leiden):
An alternative analysis for crossover studies that accounts for between
group disparities in drug response 33
Niemeyer M. C, Zwinderman A. H., Cleophas T. J. M., de Vogel E. M.
(Leiden, Sliedrecht): Crossover studies are a better format for comparing
equivalent treatments than parallel group studies 40
Zwinderman A. H., Niemeyer M. C, Kleinjans H. A. J., Cleophas T. J. M.,
(Leiden, Groningen, Zwanenburg, Sliedrecht): Application of item response
modelling for quality of life assessment: Effects of two nitrate treatment
regimens in stable angina pectoris 48
Oldham H. C, Clarke S. E. (Welwyn): In vitro identification of the human
cytochrome P450 enzymes involved in the metabolism of R(+) and
S( ) carvedilol 57
SaboA., TomicZ., Doroski H. (Novi Sad, Pristina): Time and concentration
dependence of postantibiotic effect (PAE) 63
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV012036234 |
| classification_rvk | XI 1400 |
| ctrlnum | (OCoLC)845083220 (DE-599)BVBBV012036234 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01879nam a2200421 cb4500</leader><controlfield tag="001">BV012036234</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19990413 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">980624s1998 gw d||| |||| 10||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">953901653</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3886036332</subfield><subfield code="c">hardcover : DM 85.00, sfr 77.00, S 621.00</subfield><subfield code="9">3-88603-633-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)845083220</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012036234</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 1400</subfield><subfield code="0">(DE-625)152974:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">7,41</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">What should a clinical pharmacologist know to start a clinical trial (phase I and II)?</subfield><subfield code="b">proceedings of symposium 10, 2nd congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Berlin, September 17 - 20, 1997 ; 14 tables</subfield><subfield code="c">J. Kuhlmann ... (eds.)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">München [u.a.]</subfield><subfield code="b">Zuckschwerdt</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 67 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Klinische Pharmakologie</subfield><subfield code="v">16</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Klinische Prüfung</subfield><subfield code="0">(DE-588)4031192-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1997</subfield><subfield code="z">Berlin</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Klinische Prüfung</subfield><subfield code="0">(DE-588)4031192-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kuhlmann, Jochen</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">European Association for Clinical Pharmacology and Therapeutics</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)5251718-4</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Klinische Pharmakologie</subfield><subfield code="v">16</subfield><subfield code="w">(DE-604)BV004070946</subfield><subfield code="9">16</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008144902&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="n">oe</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008144902</subfield></datafield><datafield tag="942" ind1="1" ind2="1"><subfield code="e">22/bsb</subfield><subfield code="g">471</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1997 Berlin gnd-content |
| genre_facet | Konferenzschrift 1997 Berlin |
| id | DE-604.BV012036234 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:20:31Z |
| institution | BVB |
| institution_GND | (DE-588)5251718-4 |
| isbn | 3886036332 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008144902 |
| oclc_num | 845083220 |
| open_access_boolean | |
| owner | DE-12 DE-19 DE-BY-UBM DE-355 DE-BY-UBR |
| owner_facet | DE-12 DE-19 DE-BY-UBM DE-355 DE-BY-UBR |
| physical | VIII, 67 S. graph. Darst. |
| publishDate | 1998 |
| publishDateSearch | 1998 |
| publishDateSort | 1998 |
| publisher | Zuckschwerdt |
| record_format | marc |
| series | Klinische Pharmakologie |
| series2 | Klinische Pharmakologie |
| spelling | What should a clinical pharmacologist know to start a clinical trial (phase I and II)? proceedings of symposium 10, 2nd congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Berlin, September 17 - 20, 1997 ; 14 tables J. Kuhlmann ... (eds.) München [u.a.] Zuckschwerdt 1998 VIII, 67 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Klinische Pharmakologie 16 Klinische Prüfung (DE-588)4031192-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1997 Berlin gnd-content Klinische Prüfung (DE-588)4031192-2 s DE-604 Kuhlmann, Jochen Sonstige oth European Association for Clinical Pharmacology and Therapeutics Sonstige (DE-588)5251718-4 oth Klinische Pharmakologie 16 (DE-604)BV004070946 16 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008144902&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | What should a clinical pharmacologist know to start a clinical trial (phase I and II)? proceedings of symposium 10, 2nd congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Berlin, September 17 - 20, 1997 ; 14 tables Klinische Pharmakologie Klinische Prüfung (DE-588)4031192-2 gnd |
| subject_GND | (DE-588)4031192-2 (DE-588)1071861417 |
| title | What should a clinical pharmacologist know to start a clinical trial (phase I and II)? proceedings of symposium 10, 2nd congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Berlin, September 17 - 20, 1997 ; 14 tables |
| title_auth | What should a clinical pharmacologist know to start a clinical trial (phase I and II)? proceedings of symposium 10, 2nd congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Berlin, September 17 - 20, 1997 ; 14 tables |
| title_exact_search | What should a clinical pharmacologist know to start a clinical trial (phase I and II)? proceedings of symposium 10, 2nd congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Berlin, September 17 - 20, 1997 ; 14 tables |
| title_full | What should a clinical pharmacologist know to start a clinical trial (phase I and II)? proceedings of symposium 10, 2nd congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Berlin, September 17 - 20, 1997 ; 14 tables J. Kuhlmann ... (eds.) |
| title_fullStr | What should a clinical pharmacologist know to start a clinical trial (phase I and II)? proceedings of symposium 10, 2nd congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Berlin, September 17 - 20, 1997 ; 14 tables J. Kuhlmann ... (eds.) |
| title_full_unstemmed | What should a clinical pharmacologist know to start a clinical trial (phase I and II)? proceedings of symposium 10, 2nd congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Berlin, September 17 - 20, 1997 ; 14 tables J. Kuhlmann ... (eds.) |
| title_short | What should a clinical pharmacologist know to start a clinical trial (phase I and II)? |
| title_sort | what should a clinical pharmacologist know to start a clinical trial phase i and ii proceedings of symposium 10 2nd congress of the european association for clinical pharmacology and therapeutics eacpt berlin september 17 20 1997 14 tables |
| title_sub | proceedings of symposium 10, 2nd congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), Berlin, September 17 - 20, 1997 ; 14 tables |
| topic | Klinische Prüfung (DE-588)4031192-2 gnd |
| topic_facet | Klinische Prüfung Konferenzschrift 1997 Berlin |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008144902&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV004070946 |
| work_keys_str_mv | AT kuhlmannjochen whatshouldaclinicalpharmacologistknowtostartaclinicaltrialphaseiandiiproceedingsofsymposium102ndcongressoftheeuropeanassociationforclinicalpharmacologyandtherapeuticseacptberlinseptember1720199714tables AT europeanassociationforclinicalpharmacologyandtherapeutics whatshouldaclinicalpharmacologistknowtostartaclinicaltrialphaseiandiiproceedingsofsymposium102ndcongressoftheeuropeanassociationforclinicalpharmacologyandtherapeuticseacptberlinseptember1720199714tables |